These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Medical treatment of gastroesophageal reflux disease - beyond the proton pump inhibitors. Holloway RH, Dent J. Dig Dis; 2000 Apr; 18(1):7-13. PubMed ID: 10729732 [No Abstract] [Full Text] [Related]
8. [Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease]. Ivanov AN, Iakovenko EP, Iakovenko AV. Eksp Klin Gastroenterol; 2004 Apr; (4):16-20, 107. PubMed ID: 15568661 [Abstract] [Full Text] [Related]
14. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough. Mainie I, Tutuian R, Castell DO. J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394 [Abstract] [Full Text] [Related]
15. Proton pump inhibitor failure--what are the therapeutic options? Fass R. Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545 [Abstract] [Full Text] [Related]
16. [Gastroesophageal reflux disease--diagnosis and management]. Wojtuń S, Gil J, Jałocha Ł, Błaszak A, Wojtkowiak M. Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713 [Abstract] [Full Text] [Related]
17. Infections of the esophagus and the stomach. Quiding-Järbrink M, Bove M, Dahlén G. Periodontol 2000; 2009 Feb; 49():166-78. PubMed ID: 19152533 [No Abstract] [Full Text] [Related]
18. Gastroesophageal reflux and adenocarcinoma of the esophagus. Marcus G. N Engl J Med; 1999 Aug 12; 341(7):537; author reply 537-8. PubMed ID: 10447440 [No Abstract] [Full Text] [Related]